Back to company

VEPIDAN ApS: Financial statements 2016

CVR: 17077848

VEPIDAN ApS (CVR 17077848) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 9,923,130 and a net result of DKK 4,356,991 compared with DKK 8,204,260 the year before. That is a decrease of 21.9% compared with the year before. Equity amounted to DKK 46,188,016. The solvency ratio was 79%.

Gross Profit
9,923,130 kr.
Profit/Loss
4,356,991 kr.
Equity
46,188,016 kr.
Total Assets
58,497,832 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-9.9 mio.4.4 mio.46.2 mio.-
2015-12.7 mio.8.2 mio.42 mio.-
201433.9 mio.15.8 mio.9.3 mio.33.9 mio.-
2013-15.5 mio.8.5 mio.24.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is VEPIDAN ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About VEPIDAN ApS

VEPIDAN ApS is a Danish company of the type Anpartsselskab based in Løgstør, founded in 1993. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ApS KBUS 8 NR. 3163. The management consists of Margarethe Bower. The company is owned by Hans Christian Graversen, Margarethe Bower and Peter Graversen. The company has 28 employees. In 2025, the company reported a gross profit of DKK 5,846,932 and a net result of DKK 2,949,865 compared with DKK -1,241,820 the year before. Equity amounted to DKK 109,259,532.